Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Cellectis S.A. on May 12, 2025. The filing serves to distribute a press release dated May 12, 2025, as Exhibit 99.1. The registrant is headquartered in Paris, France, and files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, no data is available regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The nature of the update is limited to the distribution of a press release, the content of which is not included in the source text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not described in the provided text. The filing references a press release but does not reproduce its substance.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing a press release (Exhibit 99.1) dated May 12, 2025.
- The source text does not contain the actual content of the press release or any financial data.
- Investors must access the full text of Exhibit 99.1 to obtain details on the company's announcements, financial results, or strategic updates.
- The report was signed by André Choulika, Chief Executive Officer.